参考文献/References:
[1] CHUNG Kianfan. Neutrophilic asthma: a distinct targetfor treatment [J].Lancet Respira Med,.2016, 4(10):765-767.
[2] NATARAJAMURTHY S H,SISTLA S,DHARMESHS M. Disruption of galectin-3 and galectin-3 bindingprotein (G3BP) interaction by dietary pectic poly-saccharides (DPP) - Arrest of metastasis, inhibitionof proliferation and induction of apoptosis [J].Inter-national Journal of Biological Macromolecules,2019,139(19):486-499.
[3] KALAYCI O, BIRBEN E, TINARI N, et al. Role of90K protein in asthma and TH2-type cytokine expres-sion[J]. Annals of Allergy, Asthma & Immunology,2004, 93(5):485-492.
[4] 中华医学会呼吸病学分会哮喘学组 . 支气管哮喘 防 治 指 南(2016 版)[J]. 中 华 结 核 和 呼 吸 杂志 ,2016,39(9):675-697.Asthma Study Group of Chinese Thoracic Society,Chinese Medical Association. Guidelines for themanagement and prevention of asthma(2016)[J].Chinese Journal of Tuberculosis and RespiratoryDiseases,2016,39(9):675-697.
[5] SIMPSON J L, SCOTT R,BOYLE M J, et al.Inflammatory subtypes in asthma: Assessmentand identification using induced sputum[J].Respirology,2006, 11(1):54-61.
[6] 中华医学会呼吸病学分会哮喘学组 . 咳嗽的诊断与 治 疗 指 南(2015 版)[J]. 中 华 结 核 和 呼 吸 杂志 ,2016,39(5):323-354.Asthma Study Group of Chinese Thoracic Society,Chinese Medical Association .Guidelines forthe diagnosis and treatment of cough(2015)[J].Chinese Journal of Tuberculosis and RespiratoryDiseases,2016,39(5):323-354.
[7] SCHLEICH F N, MANISE M,SELE J, et al.Distribution of sputum cellular phenotype in a largeasthma cohort: predicting factors for eosinophilic vsneutrophilic inflammation [J].BMC Pulm Med,2013,13(1):11.
[8] HASTIE A T, MOORE W C, MEYERS D A, etal.Analyses of asthma severity phenotypes andinflammatory proteins in subjects stratified by sputumgranulocytes,2010,125(5):1028-1036.e13.
[9] MOORE W C, HASTIE A T, LI Xingnan, et al. Sputumneutrophil counts are associated with more severeasthma phenotypes using cluster analysis[J]. AllergyClin Immunol,2014, 133(6):1557-1563.e5.
[10] AYUMI I, YOSHIHIRO K, YUSUKE E, et al.Establishment of mouse Mac-2 binding proteinenzyme-linked immunosorbent assay and its applicationfor mouse chronic liver disease models[J].HepatologyResearch, 2017, 47(9):902-909.
[11] KONO M, NAKAMURA Y, OYAMA Y, et al. Increasedlevels of serum Wisteria floribunda agglutinin-positiveMac-2 binding protein in idiopathic pulmonaryfibrosis[J].Respiratory Medicine, 2016,115:46-52.
[12] LOIMARANTA V, HEPOJOKI J, LAAKSOAHOO, et al. Galectin‐3‐binding protein: A multitaskglycoprotein with innate immunity functions in viraland bacterial infections [J]. Leukoc Biol , 2018,104(4):777-786.
[13] DEROO E P, WROBLESKI S K, SHEA E M, et al.The role of galectin-3 and galectin-3-binding protein invenous thrombosis[J].Blood, 2015,125(11):1813-1821.
[14] 谢浩 . Mac-2 结合蛋白在动脉粥样硬化和斑块去稳定性中的作用和机制研究[D].济南:山东大学,2018.XIE Hao. Role of mac-2 binding protein in athero-sclerosis and plaque destabilization and mechanismsinvolved[D].Ji’nan:Shandong University,2018.
[15] GLEISSNER C A, ERBEL C, LINDEN F, et al. Galec-tin-3 binding protein, coronary artery disease and cardio-vascular mortality: Insights from the LURIC study[J].Atherosclerosis, 2017,260:121-129.
[16] POWELL T J,SCHRECK R,MCCAL M, et al. ATumor-derived protein which provides T-cell costim-ulation through accessory cell activation[J].Journal ofImmunotherapy with Emphasis on Tumor Immunolo-gy,1995,17(4):209-221.